Back to all people

John Scott

CBER at FDA

3 appearances in the program

Sessions & presentations

PS07: Assumptions, Modelling and Risks: Utilization of ICH-M15 beyond MIDD

Presentation: Panel Discussion: Considerations on ICH M15 for supporting credibility assessment of statistical modelling approaches

Parallel · Thu, Sep 17 , 1:15 PM

Panelist

PS21: FDA's CDER and CBER PDUFA VII Guidance on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Development and Implementation

Presentation: Panel Discussion

Parallel · Thu, Sep 17 , 4:15 PM

Panelist

Plenary Session 2: Transdisciplinary Collaboration in Action: Enabling Decision-Making in an Evolving Regulatory Landscape

General Session · Thu, Sep 17 , 10:00 AM

Presenting Author

↑